Related Experiment Videos
Comparison of lytic and persistent measles virus matrix proteins by competition radioimmunoassay
Abstract:
Measles virus matrix (M) proteins were compared by competitive monoclonal antibody-binding studies. Three strains of measles and of subacute sclerosing panencephalitis viruses were found to be identical in this way. The matrix protein formed by Edmonston strain virus during a persistent infection could be distinguished from that made in the lytic virus infection. It is concluded that structural alterations in the M peptide can occur during persistence.
Insights
Measles virus matrix proteins from different strains were identical. However, structural changes in matrix proteins were observed during persistent measles virus infections, indicating alterations can occur during persistence.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Measles virus (MeV) is a significant human pathogen.
- Subacute sclerosing panencephalitis (SSPE) is a rare, fatal neurological complication of measles infection.
- The matrix (M) protein is a crucial structural component of paramyxoviruses, including MeV.
Purpose of the Study:
- To compare the matrix (M) proteins of different measles virus and SSPE virus strains.
- To investigate potential structural differences in M proteins during persistent versus lytic infections.
Main Methods:
- Competitive monoclonal antibody-binding assays were employed.
- Analysis focused on the interaction of antibodies with measles virus and SSPE virus M proteins.
Main Results:
- M proteins from three strains of measles virus and three strains of SSPE virus demonstrated identical binding patterns.
- A distinct structural difference was identified in the M protein produced by Edmonston strain measles virus during persistent infection compared to lytic infection.
Conclusions:
- Measles virus and SSPE virus share highly conserved M protein structures.
- Structural alterations in the measles virus M protein can occur during persistent infections, suggesting a mechanism for viral adaptation or immune evasion.